| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Sensus Healthcare (NASDAQ:SRTS) reported its Q4 earnings results on Thursday, February 8, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Sensus Healthcare beat estimated earnings by 116.67%, reporting an EPS of $0.26 versus an estimate of $0.12.
Revenue was down $539 thousand from the same period last year.
Last quarter the company missed on EPS by $0.07 which was followed by a 14.41% drop in the share price the next day.
Here's a look at Sensus Healthcare's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.08 | 0.13 | 0.23 |
| EPS Actual | -0.09 | -0.02 | -0.12 | 0.17 |
| Revenue Estimate | 5.88M | 4.55M | 10.13M | 12.98M |
| Revenue Actual | 3.90M | 4.53M | 3.41M | 13.11M |
To track all earnings releases for Sensus Healthcare visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SRTS
